DOI: 10.4244/EIJ-D-18-00500L

Is transcatheter aortic valve implantation feasible in patients with chronic kidney disease?

Rajkumar Doshi1*, MD, MPH; Jay Shah2, MD

We read the article “Transcatheter aortic valve implantation versus conservative treatment in chronic kidney disease patients.” by Steinmetz et al1 with great interest. This is a “non-randomised” and “single-centre” study. The authors compared transcatheter aortic valve implantation (TAVI) to conservative medical therapy in stage 3-5 chronic kidney disease (CKD) patients. They demonstrated that TAVI is associated with improved survival at one year compared to conservative therapy. This study is of vital importance as many of the physicians are hesitant to refer advanced stage CKD patients for TAVI as the data have been conflicting in previous studies. We agree that the prevalence of CKD is very high in aortic stenosis patients undergoing TAVI and that CKD alone is an independent predictor of adverse outcomes2. Many of the previous studies have demonstrated that TAVI is associated with fewer adverse events in advanced CKD patients when compared to surgical aortic valve replacement3,4. However, we have a few concerns which need to be clarified before these results gain wider uptake.

1. The results are not accompanied by the Society of Thoracic Surgeons (STS) score or EuroSCORE II which are major determinants for a decision to perform TAVI in most cases.

2. All-cause mortality for the conservative group may not be sufficient. The authors need to include cardiovascular mortality as well.

3. How many patients were already on dialysis prior to the study? Additional information is warranted as to how many patients had acute kidney injury post TAVI and how many received dialysis post TAVI.

4. Did any patient receive TAVI or surgical repair/replacement after diagnosis of aortic stenosis in the conservative management group?

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 14 Number 17
Apr 16, 2019
Volume 14 Number 17
View full issue


Key metrics

Suggested by Cory

CLINICAL RESEARCH

10.4244/EIJ-D-18-00058 Aug 3, 2018
Transcatheter aortic valve implantation versus conservative treatment in chronic kidney disease patients
Steinmetz T et al
free

Editorial

10.4244/EIJ-E-24-00006 Apr 15, 2024
The miracle of left ventricular recovery after transcatheter aortic valve implantation
Dauerman H and Lahoud R
free

10.4244/EIJV15I17A268 Apr 17, 2020
Transcatheter aortic valve implantation in nonagenarians – old…but not obsolete!
Grube E and Sinning J
free
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
38.95

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved